1. Home
  2. NOTV vs VATE Comparison

NOTV vs VATE Comparison

Compare NOTV & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

N/A

Current Price

$0.42

Market Cap

12.7M

Sector

Health Care

ML Signal

N/A

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

N/A

Current Price

$4.93

Market Cap

74.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NOTV
VATE
Founded
1974
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
74.0M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
NOTV
VATE
Price
$0.42
$4.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
553.8K
11.8K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
49.64
N/A
EPS
N/A
N/A
Revenue
$547,656,000.00
$1,107,100,000.00
Revenue This Year
$5.28
N/A
Revenue Next Year
$5.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
511.19
N/A
52 Week Low
$0.25
$4.05
52 Week High
$3.35
$9.01

Technical Indicators

Market Signals
Indicator
NOTV
VATE
Relative Strength Index (RSI) 57.99 43.51
Support Level $0.26 $4.80
Resistance Level $0.65 $5.37
Average True Range (ATR) 0.04 0.22
MACD 0.03 -0.03
Stochastic Oscillator 80.60 23.74

Price Performance

Historical Comparison
NOTV
VATE

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: